Buy this domain.

New Hope for Terminally Ill Patients As FDA Recommends Expanded Availability of Experimental Drugs | cialis online

New Hope for Terminally Ill Patients As FDA Recommends Expanded Availability of Experimental Drugs

AddThis Social Bookmark Button

Trying to resolve a controversial, complicated, long-standing issue, the U.S. Food and Drug Administration (FDA) has proposed significant rule changes that would make experimental drugs more accessible to critically ill patients. According to the agency, the regulatory changes would offer “expanded access for experimental drugs … to individual patients, small patient groups, and larger populations under a treatment plan when there is no satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition.”

“This proposed reform is carefully designed to balance several objectives,” said Dr. Andrew C. von Eschenbach, Acting FDA Commissioner. “One goal is to enable many more patients who lack satisfactory alternatives to have access to unapproved medicines, while balancing the need for safeguarding the individual patient. Another equally important goal is to ensure the continued integrity of the scientific process that brings safe and effective drugs to the market.”

At the core of the issue is a category of medications known as investigational new drugs, or INDs. These include drugs that are in development by pharmaceutical companies and that have begun to be clinically tested, but that haven’t yet won approval from the FDA. In most cases, INDs have not gone through adequate safety testing and therefore may pose unforeseen risks to patients who are using them. The new regulations would even allow access to experimental therapies that are still in “phase one” of testing; the large majority of drugs that reach phase one do not ultimately win FDA approval.

However, for seriously ill patients without any other treatment options, the risks involved often do not outweigh the potential benefits of drug treatment. In the past few decades, INDs have been considered successful in the treatment of ailments ranging from HIV/AIDS and cancer to heart disease.

It is a rather tricky balancing act for the FDA: resolving the need for rapid development of new therapies to treat critically ill patients with the desire for disciplined, scientifically rigorous safety studies. Two watchdog groups, the Washington Legal Foundation and the Abigail Alliance for Better Access to Developmental Drugs, brought a suit against the FDA in 2003 that seeks to broaden access to drugs not yet approved by the agency. The case is still in federal court and will be heard again sometime in 2007.

There are two main components to the proposed regulatory changes. The first deals with expanded access to investigational drugs. According to the FDA, this change would “clarify existing regulations and add new types of expanded access for treatment use. Under the proposal, expanded access to investigational drugs for treatment use would be available to individual patients, including in emergencies; intermediate-size patient populations; and larger populations under a treatment protocol or treatment investigational new drug application.”

The second rule change is related to how the drug companies can charge for the use of these drugs. The new rule would “clarify the circumstances in which charging for an investigational drug in a clinical trial is appropriate” and “clarify what costs can be recovered for an investigational drug.” The agency said that this change “is intended to permit charging for a broader range of investigational and expanded access uses than is explicitly permitted in current regulations.”

“FDA hopes this proposal will increase awareness in the healthcare community of the range of options available for obtaining experimental drugs for seriously ill patients,” said Dr. Janet Woodcock, FDA’s Deputy Commissioner for Operations. “By clarifying and streamlining the processes, FDA also hopes to encourage companies to make such drugs available and reduce barriers for healthcare practitioners in obtaining them.”

« »

Comments are closed.




Defective Johnson & Johnson Depuy ASR Hip Implants

The Johnson & Johnson Depuy ASR Hip Implant is suppose to last 15 years, but can fail in only a few years after surgery. Victims with faulty hip implants endure excruciating pain, pain in the groin, death of tissue in the hip joint and loss of surrounding bone. GET ALL THE FACTS NOW! CLICK HERE!

CAT Scans Radiation Exposure

If you had a CT or CAT scan and now have a band of missing hair, skin reddening or any other problems possibly related to a radiation overdose, you may have been exposed to much radiation due to incorrect settings on these machines. CONTACT US TODAY!

Water Contamination From Fracking

Hydraulic Fracturing of Fracking a way to extract natural gas from shale is contaminating water supplies across the country. Get the facts to keep your drinking water safe for your family.

Overexposure to PCBs

Many people unknowingly have been exposed to high levels of PCBs. Recently 3 schools in NY City were found to have dangerous levels of PCBs throughout. Many workers for Monsanto, General Electric, and Westinghouse were exposed to high levels of PCBs. PCBs are a dangerous toxic substance that doesn't break down easily and can cause chloracne, bleeding and neurological disorders, liver damage, spontaneous abortions, malformed babies, cancer, and death. GET THE FACTS!
Overexposure to

Great Photography

Tallis Photo, the number one photographer for great corporate, wedding, and special occasion photos. CONTACT US TODAY!

Poligrip Lawsuit

Super Poligrip or Fixodent May Cause Nerve Damage. 800-LAW-INFO

Personal Injury Lawyer Nassau County

If you or someone you love was injured CONTACT US TODAY!

Nursing Home Blog

When a loved one is abused at a nursing home, it is time to take action. STOP nursing home abuse!

Car Accident Lawyer Nassau County

If you or someone you love was injured in an auto accident CONTACT US TODAY!

Suffolk County Auto Accident Lawyer

If you or someone you love was injured in an auto accident in Suffolk County, NY CONTACT US TODAY!

Don't Be Denied Veterans Benefits

If you or someone you love was denied veterans benefits CONTACT US TODAY!

Oil Rig Spills Lawyer

Oil Rig Spills harm the environment and cause heavy losses to coastal game and fishing industries, as well as a loss of waterway usage, resulting in a loss of income to individuals and businesses, and a loss of beach front usage. Don't let a spill cause you harm, CONTACT US TODAY!

Whistle Blower

Stand up and say what you think is right. See something, say something.